Immediate Anticoagulation for Acute Cardioembolic Stroke is Still Popular in Selective Cases in Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이주헌 | - |
dc.contributor.author | Kwang-Yeol Park | - |
dc.contributor.author | 허지회 | - |
dc.contributor.author | Sun U. Kwon | - |
dc.date.available | 2019-08-23T03:00:10Z | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 1229-4101 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/35781 | - |
dc.description.abstract | Background: Although current guidelines do not recommend immediate anticoagulation therapy (IAC) for acute ischemic stroke, judicious debates are still lingering on whether it might be done for acute cardioembolic stroke (ACES). We surveyed current practice patterns of anticoagulation therapy for ACES in Korea, and analyzed their related factors. Methods: Using a web-based system, all neurology staffs of training hospitals in Korea surveyed about when and how they commenced anticoagulation therapy in the hypothetical cases with ACES. Results: Of the 359 subjects invited, 281 responded to the e-mail, of whom 76 abstained from participating. The number of participants was therefore 205 (57.1%). Although a few physicians (4.4%) always performed IAC and some (10.7%) never did, most physicians made different decisions according to infarct size and presence of hemorrhagic transformation (HTr): IAC was performed more often in cases with medium-sized or small infarct than large one (68.2% vs. 35.9%, P <0.001), and in cases without HTr (68.6% vs. 34.9%, P <0.001). The most common method of administration was ‘heparin followed by warfarin’ (68.2%), and then ‘warfarin alone’ or ‘warfarin with aspirin’. If IAC was not commenced, it resumed most commonly between 1 and 2 weeks after the onset (44.0%). Conclusion: Quite many neurologists in Korea did IAC in selective ACES, e.g. small sized infarction without HTr. Further studies are needed to prove the effi cacy of IAC therapy in this selective population. (Korean J Stroke 2011;13:120-128) | - |
dc.format.extent | 9 | - |
dc.publisher | 대한뇌졸중학회 | - |
dc.title | Immediate Anticoagulation for Acute Cardioembolic Stroke is Still Popular in Selective Cases in Korea | - |
dc.title.alternative | Immediate Anticoagulation for Acute Cardioembolic Stroke is Still Popular in Selective Cases in Korea | - |
dc.type | Article | - |
dc.identifier.bibliographicCitation | 대한뇌졸중학회지, v.13, no.3, pp 120 - 128 | - |
dc.identifier.kciid | ART001642772 | - |
dc.description.isOpenAccess | N | - |
dc.citation.endPage | 128 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 120 | - |
dc.citation.title | 대한뇌졸중학회지 | - |
dc.citation.volume | 13 | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Acute cardioembolic stroke | - |
dc.subject.keywordAuthor | Atrial fi brillation | - |
dc.subject.keywordAuthor | Anticoagulation | - |
dc.subject.keywordAuthor | Heparin | - |
dc.description.journalRegisteredClass | kciCandi | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.